[Other] Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Primary Results From AMEERA-5

Marilena Post time 3 day(s) ago | Show all posts |Read mode
Reward20points

journal:Journal of Clinical Oncology

Authors:Javier Cortés; Sara A. Hurvitz; Joyce O'Shaughnessy; Suzette Delaloge; Hiroji Iwata; Hope S. Rugo; Patrick Neven; Dheepak Kanagavel; Patrick Cohen; Gautier Paux; Sylvaine Cartot-Cotton; Maya Stefanova-Urena; Laure Deyme; Jihane Aouni; Bernard Sebastien; Aditya Bardia

Published date:--

DOI:10.1200/jco.23.02036

PDF link:https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.02036

Article link:http://dx.doi.org/10.1200/jco.23.02036

Article Source:American Society of Clinical Oncology (ASCO)


Remark:
Reply

Use magic Donate Report

All Reply1 Show all posts
cocococoa Post time Yesterday 14:51 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    80

Latest Reply

Return to the list